-
Louvre closes for the day due to strike
-
Prince Harry lawyer claims 'systematic' UK newspaper group wrongdoing as trial opens
-
Centurion Djokovic romps to Melbourne win as Swiatek, Gauff move on
-
Brignone unsure about Olympics participation ahead of World Cup comeback
-
Roger Allers, co-director of "The Lion King", dead at 76
-
Senegal awaits return of 'heroic' AFCON champions
-
Trump to charge $1bn for permanent 'peace board' membership: reports
-
Trump says world 'not secure' until US has Greenland
-
Gold hits peak, stocks sink on new Trump tariff threat
-
Champions League crunch time as pressure piles on Europe's elite
-
Harry arrives at London court for latest battle against UK newspaper
-
Swiatek survives scare to make Australian Open second round
-
Over 400 Indonesians 'released' by Cambodian scam networks: ambassador
-
Japan PM calls snap election on Feb 8 to seek stronger mandate
-
Europe readying steps against Trump tariff 'blackmail' on Greenland: Berlin
-
What is the EU's anti-coercion 'bazooka' it could use against US?
-
Infantino condemns Senegal for 'unacceptable scenes' in AFCON final
-
Gold, silver hit peaks and stocks sink on new US-EU trade fears
-
Trailblazer Eala exits Australian Open after 'overwhelming' scenes
-
Warhorse Wawrinka stays alive at farewell Australian Open
-
Bangladesh face deadline over refusal to play World Cup matches in India
-
High-speed train collision in Spain kills 39, injures dozens
-
Gold, silver hit peaks and stocks struggle on new US-EU trade fears
-
Auger-Aliassime retires in Melbourne heat with cramp
-
Melbourne home hope De Minaur 'not just making up the numbers'
-
Risking death, Indians mess with the bull at annual festival
-
Ghana's mentally ill trapped between prayer and care
-
UK, France mull social media bans for youth as debate rages
-
Japan PM to call snap election seeking stronger mandate
-
Switzerland's Ruegg sprints to second Tour Down Under title
-
China's Buddha artisans carve out a living from dying trade
-
Stroking egos key for Arbeloa as Real Madrid host Monaco
-
'I never felt like a world-class coach', says Jurgen Klopp
-
Ruthless Anisimova races into Australian Open round two
-
Australia rest Cummins, Hazlewood, Maxwell for Pakistan T20 series
-
South Korea, Italy agree to deepen AI, defence cooperation
-
Vietnam begins Communist Party congress to pick leaders
-
China's 2025 economic growth among slowest in decades
-
Gauff, Medvedev through in Australia as Djokovic begins record Slam quest
-
Who said what at 2025 Africa Cup of Nations
-
Grizzlies win in London as heckler interrupts US anthem
-
Three-time finalist Medvedev grinds into Australian Open round two
-
Auger-Aliassime retires from Melbourne first round with cramp
-
Rams fend off Bears comeback as Patriots advance in NFL playoffs
-
Thousands march in US to back Iranian anti-government protesters
-
Gotterup charges to Sony Open victory in Hawaii
-
Gold, silver hit records and stocks fall as Trump fans trade fears
-
Auger-Aliassime retires injured from Melbourne first round
-
Gauff through, Auger-Aliassime retires as Djokovic begins record quest
-
China says economy grew 5% last year, among slowest in decades
What is microRNA? Nobel-winning discovery explained
The Nobel Prize in Medicine was awarded on Monday to two US scientists for discovering microRNA, a previously unknown type of genetic switch which is hoped can pave the way for new medical breakthroughs.
But while several treatments and tests are under development using microRNAs against cancer, heart disease, viruses and other illnesses, none have actually yet reached patients.
And the world paid little attention when the new Nobel laureates Victor Ambros and Gary Ruvkun revealed their discovery decades ago, thinking it was just "something weird about worms", Cambridge University geneticist Eric Miska told AFP.
Here is an explainer about how exactly these tiny genetic switches work inside our bodies.
- What is microRNA? -
Each cell in the human body has the same set of instructions, called DNA. Some turn into brain cells, while others become muscles.
So how do the cells know what to become? The relevant part of the DNA's instructions is pointed to via a process called gene regulation.
Ribonucleic acid (RNA) normally serves as a messenger. It delivers the instructions from the DNA to proteins, which are the building blocks of life that turn cells into brains -- or muscles.
Miska gave the example of the messenger RNA vaccines rolled out against Covid-19 during the pandemic, which insert a message with new instructions to build proteins that block viruses.
But the two new Nobel winners Ambros and Ruvkun discovered a whole new type of gene regulator that had previously been overlooked by science.
Rather than being the messenger which relays information, microRNA instead acts as a switch to turn other genes off and on.
"This was a whole new level of control that we had totally missed," said Miska, who has worked on microRNA for two decades, including with the new Nobel laureates.
"The discovery of microRNAs brought an additional level of complexity by revealing that regions that were thought to be non-coding play a role in gene regulation," French researcher Benoit Ballester told AFP.
- What did the Nobel winners do? -
Back in the 1980s, Ambros and Ruvkun had been working separately on how genes interact in one-millimetre-long roundworms called C.elegans.
When they compared their work, it led to the discovery of microRNA. Ambros revealed the finding in a 1993 paper.
"Nobody really paid much attention," Miska said, explaining that most scientists at the time thought it only applied to worms.
Then in 2000, Ruvkun published research showing that microRNA is present right across the animal kingdom, including in humans and even some viruses.
"This was not just something weird that worms do, but in fact all animals and plants are totally dependent for development and normal function on them," Miska said.
More than a thousand genes that respond to microRNAs are now believed to be in the human body.
- How could this help us? -
There are numerous new treatments and tests using microRNA that are undergoing trials but none have been made widely available.
"Though there are no very clear applications available yet in microRNAs, understanding them, knowing that they exist, understanding their counter-regulatory networks, is always the first step," the Karolinska Institute's Gunilla Karlsson Hedestam told journalists in Stockholm.
MicroRNAs are particularly promising for fighting cancer because some of these switches "act as a tumour suppressor, so they put a brake on cells dividing inappropriately," Miska said.
Others, meanwhile, induce "cells to divide, which can lead to cancer", he added.
Because many viruses use microRNAs, several antiviral drugs are at varying stages of development, including for hepatitis C.
One complicating factor has been that microRNAs can be unstable.
But scientists also hope they can be used as a test called a "biomarker", which could reveal what type of cancer a patient could be suffering from, for example.
- What next? -
It also appears probable that microRNAs could be involved in the evolution of our species, Miska said.
While human brains are difficult to study, Miska hoped future research will discover more.
E.Gasser--VB